Notch inhibition as a promising new approach to cancer therapy.

Notch inhibition as a promising new approach to cancer therapy.
复制标题

DOI:
10.1007/978-1-4614-0899-4_23
复制
发表时间:
2012
影响因子:
--
通讯作者:
Purow, Benjamin
Purow, Benjamin
中科院分区:
医学4区
文献类型:
--
作者:
Purow, Benjamin

文献摘要

参考文献

被引文献

相似文献

Notch通路有力地影响干细胞的维持、发育和细胞命运,并因其在癌症中发挥的关键作用而越来越被认识到。Notch在许多癌症中促进细胞存活、血管生成和治疗耐药性,使其成为癌症治疗的一个有希望的靶点。它还与其他关键的致癌基因相互作用,提供了一种通过一次干预影响多种信号通路的方法。虽然γ -分泌酶抑制剂是临床试验中唯一形式的Notch抑制剂,但其他形式的Notch抑制剂已经开发或理论上可行。在本章中,我们回顾了Notch在癌症中抑制的基本原理,然后详细讨论了Notch抑制的各种方式,包括当前的和推测的。
The Notch pathway powerfully influences stem cell maintenance, development and cell fate and is increasingly recognized for the key roles it plays in cancer. Notch promotes cell survival, angiogenesis and treatment resistance in numerous cancers, making it a promising target for cancer therapy. It also crosstalks with other critical oncogenes, providing a means to affect numerous signaling pathways with one intervention. While the gamma-secretaase inhibitors are the only form of Notch inhibitors in clinical trials, other forms of Notch inhibition have been developed or are theoretically feasible. In this chapter we review the rationales for Notch inhibition in cancer and then discuss in detail the various modalities for Notch inhibition, both current and speculative.
DOI: 10.1016/j.leukres.2008.10.026
发表时间: 2009-05-01
期刊: LEUKEMIA RESEARCH
影响因子: 2.7
作者:
Guo, Dongmei;Ye, Jingjing;Ji, Chunyan
通讯作者: Ji, Chunyan
DOI: 10.1038/sj.onc.1203766
发表时间: 2000-08-31
期刊: ONCOGENE
影响因子: 8
作者:
Fitzgerald, K;Harrington, A;Leder, P
通讯作者: Leder, P
DOI: 10.1016/j.molbrainres.2005.02.013
发表时间: 2005-06-13
期刊: MOLECULAR BRAIN RESEARCH
影响因子: --
作者:
Hoe, HS;Rebeck, GW
通讯作者: Rebeck, GW
DOI: 10.1016/0092-8674(91)90111-b
发表时间: 1991-08-23
期刊: CELL
影响因子: 64.5
作者:
ELLISEN, LW;BIRD, J;SKLAR, J
通讯作者: SKLAR, J
DOI: 10.4049/jimmunol.167.8.4458
发表时间: 2001-10-15
影响因子: 4.4
作者:
Cheng, PY;Zlobin, A;Gabrilovich, DI
通讯作者: Gabrilovich, DI